These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29399758)

  • 21. Prevalence of heterozygous familial hypercholesterolaemia and its impact on long-term prognosis in patients with very early ST-segment elevation myocardial infarction in the era of statins.
    Rallidis LS; Triantafyllis AS; Tsirebolos G; Katsaras D; Rallidi M; Moutsatsou P; Lekakis J
    Atherosclerosis; 2016 Jun; 249():17-21. PubMed ID: 27062405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial Hypercholesterolaemia in the Era of Genetic Testing.
    Hughes DP; Viljoen A; Wierzbicki AS
    Curr Cardiol Rep; 2016 May; 18(5):42. PubMed ID: 27002618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utilisation of lipid-lowering therapies in outpatient settings in Poland: epidemiological survey Economedica Dyslipidaemia 2015.
    Szymański FM; Płatek AE; Ryś A; Semczuk-Kaczmarek K; Krzowski B; Wróbel K; Filipiak KJ
    Kardiol Pol; 2018; 76(3):648-654. PubMed ID: 29313565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in achieving treatment goals with statin use in various regions of Poland--3ST-POL study results.
    Śliż D; Filipiak KJ; Naruszewicz M; Siebert J; Mamcarz A
    Ann Agric Environ Med; 2016; 23(1):116-9. PubMed ID: 27007528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increasing the Detection of Familial Hypercholesterolaemia Using General Practice Electronic Databases.
    Vickery AW; Ryan J; Pang J; Garton-Smith J; Watts GF
    Heart Lung Circ; 2017 May; 26(5):450-454. PubMed ID: 27889294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of DNA-confirmed familial hypercholesterolaemia in young patients with myocardial infarction.
    Wald DS; Bangash FA; Bestwick JP
    Eur J Intern Med; 2015 Mar; 26(2):127-30. PubMed ID: 25682442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerivastatin: a review of its pharmacological properties and therapeutic efficacy in the management of hypercholesterolaemia.
    Plosker GL; Dunn CI; Figgitt DP
    Drugs; 2000 Nov; 60(5):1179-206. PubMed ID: 11129127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leucine 10 allelic variant in signal peptide of PCSK9 increases the LDL cholesterol-lowering effect of statins in patients with familial hypercholesterolaemia.
    Pisciotta L; Sallo R; Rabacchi C; Wunsch A; Calandra S; Bertolini S
    Nutr Metab Cardiovasc Dis; 2012 Oct; 22(10):831-5. PubMed ID: 21920719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiographic progression of coronary atherosclerosis in patients with familial hypercholesterolaemia treated with non-statin therapy: Impact of a fat-modified diet and a resin.
    Watts GF; Pang J; Chan DC; Brunt JNH; Lewis B
    Atherosclerosis; 2016 Sep; 252():82-87. PubMed ID: 27508319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of Familial Hypercholesterolemia in Hong Kong.
    Hu M; Hooper AJ; Bockxmeer FM; Watts GF; Chan JC; Tomlinson B
    J Atheroscler Thromb; 2016 May; 23(5):520-31. PubMed ID: 26875521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial.
    Stein EA; Gipe D; Bergeron J; Gaudet D; Weiss R; Dufour R; Wu R; Pordy R
    Lancet; 2012 Jul; 380(9836):29-36. PubMed ID: 22633824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The patient at risk: who should we be treating?
    Shviro I; Leitersdorf E
    Br J Clin Pract Suppl; 1996 Jan; 77A():24-7. PubMed ID: 8729587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in the prevalence, treatment, and control of hypercholesterolemia and other dyslipidemias over 10 years in Poland: the WOBASZ study.
    Pająk A; Szafraniec K; Polak M; Polakowska M; Kozela M; Piotrowski W; Kwaśniewska M; Podolecka E; Kozakiewicz K; Tykarski A; Zdrojewski T; Drygas W;
    Pol Arch Med Wewn; 2016 Jul; 126(9):642-652. PubMed ID: 27452484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving detection of familial hypercholesterolaemia in primary care using electronic audit and nurse-led clinics.
    Green P; Neely D; Humphries SE;
    J Eval Clin Pract; 2016 Jun; 22(3):341-8. PubMed ID: 26608940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. My Approach to the Patient With Familial Hypercholesterolemia.
    Safarova MS; Kullo IJ
    Mayo Clin Proc; 2016 Jun; 91(6):770-86. PubMed ID: 27261867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What is the actual epidemiology of familial hypercholesterolemia in Italy? Evidence from a National Primary Care Database.
    Guglielmi V; Bellia A; Pecchioli S; Medea G; Parretti D; Lauro D; Sbraccia P; Federici M; Cricelli I; Cricelli C; Lapi F
    Int J Cardiol; 2016 Nov; 223():701-705. PubMed ID: 27568993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency of familial hypercholesterolemia in patients with early-onset coronary artery disease admitted to a coronary care unit.
    Pang J; Poulter EB; Bell DA; Bates TR; Jefferson VL; Hillis GS; Schultz CJ; Watts GF
    J Clin Lipidol; 2015; 9(5):703-8. PubMed ID: 26350818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2017 Taiwan lipid guidelines for high risk patients.
    Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
    J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of sensitive and specific age- and gender-specific low-density lipoprotein cholesterol cutoffs for diagnosis of first-degree relatives with familial hypercholesterolaemia in cascade testing.
    Starr B; Hadfield SG; Hutten BA; Lansberg PJ; Leren TP; Damgaard D; Neil HA; Humphries SE
    Clin Chem Lab Med; 2008; 46(6):791-803. PubMed ID: 18601600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up.
    Perez de Isla L; Alonso R; Watts GF; Mata N; Saltijeral Cerezo A; Muñiz O; Fuentes F; Diaz-Diaz JL; de Andrés R; Zambón D; Rubio-Marin P; Barba-Romero MA; Saenz P; Sanchez Muñoz-Torrero JF; Martinez-Faedo C; Miramontes-Gonzalez JP; Badimón L; Mata P;
    J Am Coll Cardiol; 2016 Mar; 67(11):1278-85. PubMed ID: 26988947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.